IP Verse

Site-Directed Modification Of Fviii - EP2772500

The patent EP2772500 was granted to Bayer Healthcare on Dec 25, 2019. The application was originally filed on Nov 14, 2005 under application number EP14165736A. The patent is currently recorded with a legal status of "Revoked".

EP2772500

BAYER HEALTHCARE
Application Number
EP14165736A
Filing Date
Nov 14, 2005
Status
Revoked
Aug 19, 2022
Grant Date
Dec 25, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MARKS & CLERKDec 27, 2019MARKS & CLERKADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS4970300
DESCRIPTIONUS6048720
DESCRIPTIONUS6136599
DESCRIPTIONWO2004075923
DESCRIPTIONWO9012874
DESCRIPTIONWO9415625
OPPOSITIONEP0922446
OPPOSITIONWO0042175
OPPOSITIONWO2004075923
OPPOSITIONWO9012874
OPPOSITIONWO9903887
SEARCHUS6753165
SEARCHWO2004075923
SEARCHWO9415625
SEARCHWO9711957

Non-Patent Literature (NPL) Citations (63) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ANDERSSON ET AL., PROC. NATL. ACAD. SCI., (1986), vol. 83, page 2979-
DESCRIPTION- BARROW, R. ET AL., BLOOD, (2000), vol. 95, no. 2, pages 564 - 8-
DESCRIPTION- BOVENSCHEN ET AL., BLOOD, (2005), vol. 106, pages 906 - 910-
DESCRIPTION- BOVENSCHEN ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 9370 - 9377-
DESCRIPTION- BOVENSCHEN N ET AL., J. BIOL. CHEM., (2003), vol. 278, no. 11, pages 9370 - 7-
DESCRIPTION- EWENSTEIN ET AL., SEMIN. HEMATOL., (2004), vol. 41, pages 1 - 16-
DESCRIPTION- FAY ET AL., J. BIOL. CHEM., (1991), vol. 266, pages 8957 - 8962-
DESCRIPTION- FAY ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 20522 - 20527-
DESCRIPTION- FOSTER ET AL., J. BIOL. CHEM., (1988), vol. 263, pages 5230 - 5234-
DESCRIPTION- FULCHER, C. ET AL., PROC. NATL. ACAD. SCI., (1985), vol. 2, no. 22, pages 7728 - 32-
DESCRIPTION- GILBERT ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 6374 - 6381-
DESCRIPTION- GRUPPO ET AL., HAEMOPHILIA, (2003), vol. 9, pages 251 - 260-
DESCRIPTION- HARRIS ET AL., CLINICAL PHARMACOKINETICS, (2001), vol. 40, pages 539 - 51-
DESCRIPTION- HEALEY, J. ET AL., J. BIOL. CHEM., (1995), vol. 270, no. 24, pages 14505 - 9-
DESCRIPTION- JACQUEMIN ET AL., BLOOD, (2000), vol. 96, pages 958 - 965-
DESCRIPTION- KAUFMAN ET AL., J. BIOL. CHEM., (1988), vol. 263, page 6352-
DESCRIPTION- KOZLOWSKI ET AL., BIODRUGS, (2001), vol. 15, pages 419 - 429-
DESCRIPTION- LEE ET AL., PHARM DEV TECHNOL., (1999), vol. 4, pages 269 - 275-
DESCRIPTION- LENTING ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 1935 - 1940-
DESCRIPTION- LENTING ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 23734 - 23739-
DESCRIPTION- LIND, P ET AL., EUR. J. BIOCHEM., (1995), vol. 232, pages 19 - 27-
DESCRIPTION- LUBIN ET AL., J. BIOL. CHEM., (1994), vol. 269, no. 12, pages 8639 - 41-
DESCRIPTION- LUBIN, I., J. BIOL. CHEM., vol. 272, no. 48, pages 30191 - 5-
DESCRIPTION- MCMULLEN ET AL., PROTEIN SCI., (1995), vol. 4, pages 740 - 746-
DESCRIPTION- NOGAMI ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 15763 - 15771-
DESCRIPTION- OLDENBURG ET AL., HAEMOPHILIA, (2004), vol. 10, no. 4, pages 133 - 139-
DESCRIPTION- PARKER, E. ET AL., BLOOD, (2004), vol. 104, no. 3, pages 704 - 10-
DESCRIPTION- PITTMAN ET AL., PROC. NATL. ACAD. SCI., (2001), vol. 276, pages 12434 - 12439-
DESCRIPTION- REGAN ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 3982 - 3987-
DESCRIPTION- SAENKO ET AL., HAEMOPHILIA, (2002), vol. 8, pages 1 - 11-
DESCRIPTION- SAENKO ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 37685 - 37692-
DESCRIPTION- SARAFANOV ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 11970 - 11979-
DESCRIPTION- SCANDELLA, D. ET AL., BLOOD, (1989), vol. 74, no. 5, pages 1618 - 26-
DESCRIPTION- SCANDELLA, D. ET AL., BLOOD, (1993), vol. 82, no. 6, pages 1767 - 75-
DESCRIPTION- SCANDELLA, D. ET AL., PROC. NATL. ACAD. SCI., (1988), vol. 85, no. 16, pages 6152 - 6-
DESCRIPTION- SCANDELLA, D. ET AL., THROMB HAEMOST., (1992), vol. 67, no. 6, pages 665 - 71-
DESCRIPTION- SCANDELLA ET AL., THROMB. HAEMOST., (1992), vol. 67, pages 665 - 71-
DESCRIPTION- SPIEGEL, P. ET AL., J. BIOL. CHEM., (2004), vol. 279, no. 51, pages 53691 - 8-
DESCRIPTION- STOILOVA-MCPHIE, S. ET AL., BLOOD, (2002), vol. 99, no. 4, pages 1215 - 23-
DESCRIPTION- STOLIOVA-MCPHIE ET AL., BLOOD, (2002), vol. 99, pages 1215 - 1223-
DESCRIPTION- THOMPSON, SEMIN. HEMATOL., (2003), vol. 29, pages 11 - 22-
DESCRIPTION- WANG ET AL., BIOCHEMISTRY, (2000), vol. 39, pages 10634 - 10640-
DESCRIPTION- WANG ET AL., INTERNATIONAL J. PHARMACEUTICS, (2003), vol. 259, pages 1 - 15-
OPPOSITION- BENHAR et al., The Journal of Biological Chemistry, (19940000), vol. 269, no. 18, pages 13398 - 13404, XP055213946-
OPPOSITION- Declaration of Professor Michael Przybylski-
OPPOSITION- KUAN et al., The Journal of Biological Chemistry, (19940000), vol. 269, no. 10, pages 7610 - 7616, XP055666928-
OPPOSITION- LENTING et al., Blood, (19980000), vol. 92, no. 11, pages 3983 - 3996, XP002333863-
OPPOSITION- MCMULLEN et al., Protein Science, (19950000), vol. 4, no. 4, pages 740 - 6, XP055666938
OPPOSITION- VERONESE, Biomaterials, (20010000), vol. 22, pages 405 - 417, XP004227886
OPPOSITION- CHAPMAN, Advanced Drug Delivery Reviews, (20020000), vol. 54, pages 531 - 545, XP002300924
OPPOSITION- ESPOSITO et al., Advanced Drug Delivery Reviews, (20030000), vol. 55, pages 1279 - 1291, XP008040600
OPPOSITION- FOSER et al., Protein Expression and Purification, (20030000), vol. 30, pages 78 - 87, XP004432807
OPPOSITION- LEE et al., Pharmaceutical Research, (20020600), vol. 19, no. 6, XP002904848
OPPOSITION- GOODSON et al., Biotechnology, (19900000), vol. 8, pages 343 - 346, XP002949248
OPPOSITION- HARRIS et al., Nature Reviews Drug Discovery, (20030000), vol. 2, pages 214 - 221, XP009042217
OPPOSITION- SZAJLI et al., Molecular & Cellular Proteomics, (20080712), pages 2410 - 2418, XP055260168
OPPOSITION- MEI et al., Blood, vol. 116, no. 2, pages 270 - 279, XP002618133
OPPOSITION- ANNESLEY, Clinical Chemistry, (20030000), vol. 49, no. 7, pages 1041 - 1044, XP055153860
OPPOSITION- PASUT et al., Expert Opinion on Therapeutic Patents, (20050000), vol. 14, no. 6, pages 859 - 894, XP001202106
OPPOSITION- YOUNGSTER et al., Current Pharmaceutical Design, (20020000), vol. 8, no. 24, pages 2139 - 2157, XP008064341
SEARCH- SAKURAGAWA N ET AL, "STUDIES ON THE STABILITY OF FACTOR VIII MODIFIED BY POLYETHYLENE GLYCOL", ACTA MEDICA BIOLOGICA, NIIGATA DAIGAKU IGAKUBU, NIIGATA, JP, (19880101), vol. 36, no. 1, ISSN 0567-7734, pages 1 - 05, XP009011547 [X] 1-15 * the whole document *-
SEARCH- VERONESE F M, "Peptide and protein PEGylation - a review of problems and solutions", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, (20010301), vol. 22, no. 5, ISSN 0142-9612, pages 405 - 417, XP004227886 [A] 1-15 * 7. PEGylation at cysteine residue; page 410 *
SEARCH- KOCHENDOERFER G, "CHEMICAL AND BIOLOGICAL PROPERTIES OF POLYMER-MODIFIED PROTEINS", EXPERT OPINION ON BIOLOGICAL THERAPY, ASHLEY, LONDON, GB, (20030101), vol. 3, no. 8, ISSN 1471-2598, pages 1253 - 1261, XP008036528 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents